Page 82 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology Gut microbiota and hyperuricemia: Mechanisms and therapeutic strategies

2024;63(3):697-711. doi: 10.1016/j.berh.2020.101501
doi: 10.1007/s00394-023-03291-w 68. Jordan A, Gresser U. Side effects and interactions of the
xanthine oxidase inhibitor febuxostat. Pharmaceuticals
59. Méndez-Salazar EO, Vázquez-Mellado J, Casimiro-Soriguer
CS, et al. Taxonomic variations in the gut microbiome of (Basel). 2018;11(2):51.
gout patients with and without tophi might have a functional doi: 10.3390/ph11020051
impact on urate metabolism. Mol Med. 2021;27(1):50.
69. White WB, Saag KG, Becker MA, et al. Cardiovascular safety
doi: 10.1186/s10020-021-00311-5 of febuxostat or allopurinol in patients with gout. N Engl J
Med. 2018;378(13):1200-1210.
60. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal
anti-inflammatory drugs (NSAIDs) and organ damage: doi: 10.1056/NEJMoa1710895
A current perspective. Biochem Pharmacol. 2020;180:114147.
70. Kawenoki-Minc E, Brzozowska-Jurkowska AM.
doi: 10.1016/j.bcp.2020.114147 Zastosowanie benzbromaronu w leczeniu chorych na dne
[Benzbromarone in the treatment of gout]. Reumatologia.
61. Singh AK, Durairajan SSK, Iyaswamy A, Williams
LL. Elucidating the role of gut microbiota dysbiosis in 1980;18(1):61-67.
hyperuricemia and gout: Insights and therapeutic strategies. 71. Shen Z, Rowlings C, Kerr B, et al. Pharmacokinetics,
World J Gastroenterol. 2024;30(40):4404-4410. pharmacodynamics, and safety of lesinurad, a selective uric
acid reabsorption inhibitor, in healthy adult males. Drug Des
doi: 10.3748/wjg.v30.i40.4404
Dev Ther. 2015;9:3423-3434.
62. Cao J, Wang T, Liu Y, et al. Lactobacillus fermentum
F40-4 ameliorates hyperuricemia by modulating the gut doi: 10.2147/DDDT.S85193
microbiota and alleviating inflammation in mice [published 72. Pérez-Ruiz F, Jansen T, Tausche AK, Juárez-Campo M,
correction appears in Food Funct. 2024;15(4):2328. Gurunath RK, Richette P. Efficacy and safety of lesinurad
for the treatment of hyperuricemia in gout. Drugs Context.
doi: 10.1039/d4fo90016b]. Food Funct. 2023;14(7):3259-
3268. 2019;8:212581.
doi: 10.7573/dic.212581
doi: 10.1039/d2fo03701g
73. Shi X, Zhao T, da Silva-Júnior EF, et al. Novel urate
63. Cao J, Liu Q, Hao H, et al. Lactobacillus paracasei X11
ameliorates hyperuricemia and modulates gut microbiota in transporter 1 (URAT1) inhibitors: A review of recent
mice [retracted in: Front Immunol. 2024;15:1517021. patent literature (2020-present). Expert Opin Ther Pat.
2022;32(12):1175-1184.
doi: 10.3389/fimmu.2024.1517021]. Front Immunol.
2022;13:940228. doi: 10.1080/13543776.2022.2165911
74. Schlesinger N, Lipsky PE. Pegloticase treatment of chronic
doi: 10.3389/fimmu.2022.940228
refractory gout: Update on efficacy and safety. Semin
64. Hamada T, Hisatome I, Wakimizu T, et al. Lactobacillus Arthritis Rheum. 2020;50(3S):S31-S38.
gasseri PA-3 reduces serum uric acid levels in patients with
marginal hyperuricemia. Nucleosides Nucleotides Nucleic doi: 10.1016/j.semarthrit.2020.04.011
Acids. 2022;41(4):361-369. 75. Sundy JS, Baraf HS, Yood RA, et al. Efficacy and tolerability
of pegloticase for the treatment of chronic gout in patients
doi: 10.1080/15257770.2022.2039702
refractory to conventional treatment: Two randomized
65. Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. controlled trials. JAMA. 2011;306(7):711-720.
Hypouricaemic effects of yoghurt containing Lactobacillus
gasseri PA-3 in patients with hyperuricaemia and/or gout: doi: 10.1001/jama.2011.1169
A randomised, double-blind, placebo-controlled study. Mod 76. Stamp LK, Merriman TR, Singh JA. Expert opinion on
Rheumatol. 2019;29(1):146-150. emerging urate-lowering therapies. Expert Opin Emerg
Drugs. 2018;23(3):201-209.
doi: 10.1080/14397595.2018.1442183
doi: 10.1080/14728214.2018.1527899
66. Kuo YW, Hsieh SH, Chen JF, et al. Lactobacillus reuteri
TSR332 and Lactobacillus fermentum TSF331 stabilize 77. Zhou X, Zhang B, Zhao X, et al. Chlorogenic acid
serum uric acid levels and prevent hyperuricemia in rats. supplementation ameliorates hyperuricemia, relieves renal
PeerJ. 2021;9:e11209. inflammation, and modulates intestinal homeostasis. Food
Funct. 2021;12(12):5637-5649.
doi: 10.7717/peerj.11209
doi: 10.1039/d0fo03199b
67. Stamp LK, Chapman PT. Allopurinol hypersensitivity:
Pathogenesis and prevention. Best Pract Res Clin Rheumatol. 78. Gao J, Azad MAK, Han H, Wan D, Li T. Impact of prebiotics
2020;34(4):101501. on enteric diseases and oxidative stress. Curr Pharm Des.

Volume 9 Issue 2 (2025) 74 doi: 10.36922/ejmo.8579